Cancer Research

Research

Clinical trials using cutting-edge therapies.

At Ingalls Cancer Care, our clinical trial patients are among the first to benefit from new therapies. Clinical trials are carefully regulated studies that meet or exceed the current approved standard of care and create opportunities for patients to receive new, potentially more effective therapies, including medications not yet approved by the FDA.

Ingalls collaborates with the National Cancer Institute, the nation's leading cancer treatment centers, and locally with Chicago's major university hospitals to design and implement a wide array of clinical trials for nearly every cancer site in the body. And best of all, it's close to home.

The Ingalls Cancer Care Research Team includes a unique group of doctors who are credentialed in cancer research. Our doctors are publishing, teaching and leading others in the field. What's more, our doctors are applying what they learn to improve care and outcomes for Ingalls' cancer patients. More options. More cutting-edge therapies. More opportunities to win the battle against cancer. To learn more about how Ingalls is finding more answers to beat cancer, read the Clinical Trials brochure.

Awards and Recognition

Ingalls Cancer Care has received numerous national awards and distinctions for its superior cancer program, including:

  • Outstanding Achievement Award

    In 2009, Ingalls was named a recipient of the Outstanding Achievement Award from the American College of Surgeons’ Commission on Cancer (CoC). Ingalls is one of only 80 institutions nationwide to earn the award, along with the CoC’s three-year re-accreditation with commendation. Fewer than 20 percent of cancer programs in the United States attain this superior recognition. The CoC assesses cancer programs in six different areas, including cancer committee leadership, cancer data management, clinical services, research, community outreach and quality improvement. Commission approval is given only to institutions like Ingalls that voluntarily commit to excellent cancer care and a rigorous review of their performance.

  • National Accreditation Program for Breast Centers

    Ingalls Memorial Hospital’s Richard K. Desser, M.D., Comprehensive Breast Center earned a perfect score and a three-year accreditation from the National Accreditation Program for Breast Centers (NAPBC) in 2009. Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance. Currently, Ingalls is one of only five accredited breast centers in Illinois, and the only accredited center in the south suburbs. The NAPBC is dedicated to improving the quality of care for patients with breast cancer and other diseases of the breast. It defines 27 breast program standards and 17 care components – from medical oncology consultation/treatment and surgical care to research, a survivorship program and more – that collectively provide the most coordinated, comprehensive care for patients diagnosed with diseases of the breast. The NAPBC application and on-site survey process is rigorous, and NAPBC-accredited centers like Ingalls Richard K. Desser Breast Center must be recertified every three years.

  • Breast Imaging Center of Excellence

    Ingalls Memorial Hospital and the Richard K. Desser, M.D., Comprehensive Breast Center in Tinley Park were designated a Breast Imaging Center of Excellence by the American College of Radiology (ACR) in 2010. The designation signifies that Ingalls meets the highest standards of the radiology profession for breast imaging and diagnosis, and has demonstrated excellence and achieved full accreditation in mammography, breast ultrasound, breast ultrasound-guided biopsy and stereotactic breast biopsy. Ingalls is the first and only hospital in the south suburbs to achieve the designation.

    The ACR, a national membership organization serving radiologists, radiation oncologists, interventional radiologists and medical physicists, is recognized as a leader in accreditation of medical imaging and radiation oncology. Ingalls voluntarily underwent the ACR’s rigorous review process and was certified as meeting nationally accepted standards.

Leading the Way in the South Suburbs

Ingalls has been treating cancer longer than any hospital in south suburban Chicago. In fact, we built the first freestanding cancer center in Tinley Park and today, the center offers the most advanced diagnostic and treatment capabilities in the region, including the latest digital mammography. What’s more, Ingalls is one of only two hospitals in Illinois whose radiation oncology program is accredited by the American College of Radiology. We are a nationally accredited breast center, and a recipient of the Outstanding Achievement award by the American College of Surgeons Commission on Cancer. These prestigious accreditations are granted to only a few cancer centers in the state of Illinois.

Read more about:

  • The Area's Only Freestanding Cancer Center - Right in Tinley Park

    Ingalls is home to the first freestanding cancer care center in Illinois - the Ingalls Cancer Care Center in Tinley Park. Equipped with the most advanced diagnostic and treatment capabilities available anywhere, the center offers a comfortable, convenient setting close to where many of our patients live and work. On-site technologies include all of those available at our main campus in Harvey, plus intensity modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), positron emission tomography (PET) scanning, high-field MRI, a 16-slice PET/CT scanner, and nuclear scanners. Patients also have access to minimally invasive interventional cancer treatments; multidisciplinary teams for consultation and treatment; dedicated outpatient and in-home rehabilitation and therapy services; and hospice care available at home or in the hospital.

    The Ingalls Cancer Care Center in Tinley Park also offers the nationally acclaimed Richard K. Desser, M.D., Comprehensive Breast Center, for the most complete breast care in the South Suburbs.

  • The Richard K. Desser, M.D., Comprehensive Breast Center

    Our nationally accredited Richard K. Desser, M.D., Comprehensive Breast Center offers the most complete breast care anywhere in the South Suburbs. Our team of caring medical professionals provides private, state-of-the-art, individualized care for women with breast health issues – in one convenient location. When needed, patients can receive the professional opinion of a surgeon, radiologist, medical oncologist, radiation oncologist and a plastic surgeon. What’s more, every patient receives the expert guidance of our specially trained breast health nurse navigator who answers questions, educates and assists patients in every aspect of their care - from diagnosis through treatment.

    Ingalls Desser Center features some of the most sophisticated equipment available for the diagnosis of breast problems. Further, the center has been certified by the Food and Drug Administration (FDA) and the American College of Radiology (ACR), passing stringent guidelines for expertise, accuracy and reliability. The center offers the following tools for effective breast care:

    • Stereotactic Breast Biopsy. The Desser Center provides stereotactic breast biopsy and ultrasound-guided breast biopsy – outpatient, non-surgical procedures that in some cases replace surgical biopsies for those breast lumps that require further evaluation. You only need local anesthesia; you’re home the same day, and there is no scar.
    • Digital Mammography. Ingalls now offers the area’s most sophisticated digital mammograms at several convenient locations, including the main hospital in Harvey; the Desser Center in Tinley Park; and the Ingalls Family Care Centers in Flossmoor and Calumet City.
    • Magnetic Resonance Imaging (MRI). The Desser Center uses MRI (performed at the hospital) in very select cases, including the detection of silicone breast implant leakage.
    • PET/CT Scan. Doctors now have the capability to more precisely detect and localize tumors while offering patients faster turnaround times thanks to a dedicated PET/CT (positron emission tomography/computed tomography) scanner at the Ingalls Family Care Center in Tinley Park.

    With breast care, education is as important as regular examinations. At the Desser Center, we’ll take the time to discuss what you need to know to maintain breast health. We also have an extensive library of books, pamphlets and computer-access videos. Depending on your needs, we may teach you how to perform an effective breast self-examination; refer you to a support group in your area; or provide information on newly recommended treatments. Through education, you can do a lot to help yourself and those around you receive the best care possible.

Cancer Care at Ingalls Video

Better Outcomes. Fewer Side Effects.

View Video

Clinical Trials

Breast

Clinical Trial #: NSABP B-43 (NCT 00769379)

Read More

Colon/Rectal Stage III

Clinical Trial #: CALGB 80702 (NCT 01150045)

Read More

Head and Neck Stage II - Stage III

Clinical Trial #: RTOG 0920 (NCT 00956007)

Read More

Head and Neck Stage IV

Clinical Trial #: U of C 09-266-B (NCT 01111058)

Read More

Head and Neck

Clinical Trial #: ECOG E1305 (NCT 00588770)

Read More

Hepatocellular Stage II - Stage III

Clinical Trial #: ECOG E1208 (NCT 01004978)

Read More

Lung (small cell) Stage IV

Clinical Trial #: RTOG 0937 (NCT 01055197)

Read More

Lymphoma

Clinical Trial #: U of C 09-443-A (NCT 01076543)

Read More

Pancreas

Clinical Trial #: RTOG 0848 (NCT 01013649)

Read More

Prostate Stage I- Stage III

Clinical Trial #: RTOG 0534 (NCT 00567580)

Read More

Breast Stage IV

Clinical Trial #: ECOG 2108 (NCT 01242800)

Read More

Breast Stage I- Stage III

Clinical Trial #: SWOG S1007 (NCT 01272037)

Read More

Breast Stage I- Stage III

Clinical Trial #: NSABP B-47 (NCT 01275677)

Read More

Melanoma Stage III- Stage IV

Clinical Trial #: ECOG E1609 (NCT 01274338)

Read More

Thyroid

Clinical Trial #: U of C 10-182-B (NCT 01208051)

Read More

Gastric Stage IIA- Stage IIIA

Clinical Trial #: RTOG 1010 (NCT 01196390)

Read More

Lymphoma

Clinical Trial #: Abbott M12-630 (NCT 01594229)

Read More

Prostate Stage IV

Clinical Trial #: U of C 11-0709 (NCT 01543776)

Read More

Lymphoma Stage III- Stage IV

Clinical Trial #: CALGB 50904 (NCT 01286272)

Read More

Head and Neck Stage III- Stage IV

Clinical Trial #: Boehringer Ingelheim 1200.131 (NCT 01345669)

Read More

Breast

Clinical Trial #: Alliance A221102 (NCT 01573442)

Read More

Lung (small cell)

Clinical Trial #: U of C 12-1726 (NCT 01803269)

Read More

Melanoma Stage III- Stage IV

Clinical Trial #: ECOG E3611 (NCT 01708941)

Read More

Colon/Rectal

Clinical Trial #: Genentech/Roche ML28442 (NCT 01765582)

Read More

Breast

Clinical Trial #: ACOSOG Z11102 (NCT 01556243)

Read More

Colon/Rectal Stage IIA - Stage IIIB

Clinical Trial #: Alliance N1048 (NCT 01515787)

Read More

Endometrial/Cervical

Clinical Trial #: RTOG 1203 (NCT 01672892)

Read More

Breast Stage I - Stage IIIA

Clinical Trial #: NSABP B51/ RTOG 1304 (NCT 01872975)

Read More

Breast

Clinical Trial #: SWOG S1207 (NCT 01674140)

Read More

Breast Stage IV

Clinical Trial #: PUMA-NER-1301 (NCT 01808573)

Read More

Breast

Clinical Trial #: ECOG E1Z11 (NCT 01824836)

Read More

Carcinoid

Clinical Trial #: Alliance A021202 (NCT 01841736)

Read More

Pancreas Stage IV

Clinical Trial #: SCRI GI184 (NCT 01844817)

Read More

Lymphoma Stage II, III, or IV

Clinical Trial #: ECOG E1412 (NCT 01856192)

Read More

Breast Stage I - Stage II

Clinical Trial #: Alliance A011104 (NCT 01805076)

Read More

Pancreas Stage II, III, or IV

Clinical Trial #: U of C 13-0233 (NCT 01585805)

Read More

Breast Stage IV

Clinical Trial #: Novartis CLEE011A2301 (NCT 01958021)

Read More

Leukemia

Clinical Trial #: Roche GO28667 (NCT 02005471)

Read More

Lung (non-small cell) Stage IIIB - Stage IV

Clinical Trial #: Roche GO28915 (NCT 02008227)

Read More

Breast Stage IIA - Stage IIIC

Clinical Trial #: Alliance A011106 (NCT 01953588)

Read More

Multiple Myeloma

Clinical Trial #: SWOG S1211 (NCT 01668719)

Read More

Breast Stage IB- Stage IIIA

Clinical Trial #: Alliance A011202 (NCT 01901094)

Read More

Breast

Clinical Trial #: SWOG S1202 (NCT 01598298)

Read More

Leukemia

Clinical Trial #: Genentech GO28440 (NCT 01671904)

Read More

Breast

Clinical Trial #: Celldex Therapeutics CDX011-04 (NCT 01997333)

Read More

Bladder Stage IV

Clinical Trial #: Roche GO29293 (NCT 02108652)

Read More

Breast

Clinical Trial #: Genomic Health 14-002

Read More

Pancreas

Clinical Trial #: Incyte 18424-363

Read More

Breast Stage III- Stage IV

Clinical Trial #: ECOG E2112

Read More

Lung (non-small cell) Stage IV

Clinical Trial #: SCRI LUN261

Read More

Lymphoma

Clinical Trial #: Roche/Abbvie BO29337

Read More

Lung (non-small cell) Stage IIIB - Stage IV

Clinical Trial #: Abbvie M11-089

Read More

Prostate Stage IV

Clinical Trial #: Alliance A031201

Read More

Breast Stage IB - Stage III

Clinical Trial #: NSABP B52

Read More

Success Stories

Ingalls Among First in Nation to Offer Investigative Drug for Leukemia

Unique Liver Tumor Treatment Provides Hope for South Side Native

Read More

Proper Nutrition is a Must for Cancer Patients

Read More

'Accidental Find' of Melanoma Saves Park Forest Woman

Read More

Our Experts Take Cancer Care Personally

Read More

Ingalls Honored for Outstanding Cancer Achievement

Read More

Dolton Man Faces Lung Cancer with a Positive Attitude

Read More

Ingalls Doctors Put the ‘Deep Freeze’ on Tumors and Save Patient’s Kidneys

Read More

Ingalls Introduces Ambassadors for Cancer Research

Read More

Ingalls Enrolling Patients in National Pancreatic Cancer Study

Read More

Chicago Woman is 'Poster Child' for Successful Breast Cancer Treatment

Read More

Helping Cancer Survivors Triumph Over Stress and Depression

Read More

New Therapy for Patients with Inoperable Liver Cancer

Read More

Rogers & Hollands Jewelers Promise of Hope.

The Rogers & Hollands Jewelers ‘Promise of Hope Collection’ was inspired by company matriarch, Juell Kadet. As a 30-year cancer survivor, she has been at the forefront of raising funds for cancer research to further Ingalls Hospital's Cancer Care Clinical Trials.

When purchasing a Promise of Hope piece, 20% of the net proceeds from your purchase are donated to the Cancer Care Clinical Trials at Ingalls Hospital.

To view the collection, visit: Promise of Hope.

Ingalls Cancer Care Resources

Ingalls Cancer Care Patient Guide

Read More

Nurse Navigator. Helping you find your way.

Read More

Healing Stories: Find comfort in knowing...

Read More

Ingals Clinical Trials. More Answers to beat cancer.

Read More

Ingalls Resources

Other Resources